Informations générales (source: ClinicalTrials.gov)
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis (STEA-MRI)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
mai 2017
septembre 2018
29 juin 2024
Evaluation of 4 MRI methods (PDFF 3, 6 and 11 gradient echoes and Spectroscopy) compared
to the reference method (liver biopsy) in quantification of hepatic steatosis
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU Clermont-Ferrand - 63003 - Clermont-Ferrand - France | Patrick LACARIN | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- patients undergoing hepatic biopsy (trans-parietal or trans-jugular) in the context
of liver disease
- signature of written consent
- patients undergoing hepatic biopsy (trans-parietal or trans-jugular) in the context
of liver disease
- signature of written consent
- Contra-indications to MRI
- Refusal of protocol
- underage patients and protected adults